|
Behavioral Trial for the Treatment of Methamphetamine Dependence - 1 Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Behavioral Trial for the Treatment of Methamphetamine Dependence - 1 conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Behavioral Trial for the Treatment of Methamphetamine Dependence - 1 Clinical research trials and Behavioral Trial for the Treatment of Methamphetamine Dependence - 1 healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Behavioral Trial for the Treatment of Methamphetamine Dependence - 1. Behavioral Trial for the Treatment of Methamphetamine Dependence - 1 Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Behavioral Trial for the Treatment of Methamphetamine Dependence - 1 clinical trial. Test subjects typically receive the most effective healthcare possible for their Behavioral Trial for the Treatment of Methamphetamine Dependence - 1 condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Behavioral Trial for the Treatment of Methamphetamine Dependence - 1  Behavioral Trial for the Treatment of Methamphetamine Dependence - 1
Behavioral Trial for the Treatment of Methamphetamine Dependence - 1
For Condition: Substance-Related Disorders
Status: No longer recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: A behavioral trial for the treatment of methamphetamine dependence.
Details: To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a "platform" in future pharmacotherapy trials.
Eligibility:
Study Type: Interventional, Treatment, Uncontrolled
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence. Exclusion Criteria: Additional criteria available during screening at the site.
Total Enrollment: 50
Location and Contact Information:
Overall Study Official:
RichardRawson, Principal Investigator, National Institute on Drug Abuse (NIDA)
Powell Chemical Dependency Center
Des Moines, Iowa,
United States
Matrix Institute on Addictions
Costa Mesa, California, 92627
United States
South Bay Treatment Center
Chula Vista, California, 91911
United States
John A. Burns School of Medicine
Honolulu, Hawaii, 96813
United States
Comprehensive Mental Health Services, Inc
Independence, Missouri, 64052
United States
Additional Information:
Study ID Numbers: NIDA-CTO-0009-1;
Study Start Date: July 2001
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00033124
Other Substance-Related Disorders Studies:
1. Methylphenidate Raclopride PET test - 11
2. Pergolide Treatment for Substance Abusers - 4
3. Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence - 1
4. Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
5. Family Intervention for Mental Illness and Substance Abuse
Related Studies:
Other Substance-Related Disorders Clinical Trials
Other Iowa Clinical Trials
Other Des Moines Clinical Trials
Behavioral Trial for the Treatment of Methamphetamine Dependence - 1
|
|
|
|
|
|
|
|
